BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9745824)

  • 1. [Impact of anti-retroviral treatment with protease inhibitors on the evolution of cytomegalovirus retinitis in the patient carrying acquired immunodeficiency syndrome].
    Postelmans L; Gerard M; Sommereijns B; Caspers L; Clumeck N; Libert J
    Bull Soc Belge Ophtalmol; 1997; 267():133-44. PubMed ID: 9745824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
    Labetoulle M; Goujard C; Frau E; Rogier H; Niessen F; Rudent A; Lantz O; Lecointe D; Furlan V; Delfraissy JF; Offret H
    J Fr Ophtalmol; 1998 Oct; 21(8):567-76. PubMed ID: 9833222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytomegalovirus retinitis in patients with human immunodeficiency virus infection].
    Mesarić B; Begovac J; Ugrinović N; Babić K; Lisić M
    Lijec Vjesn; 1998 May; 120(5):106-10. PubMed ID: 9748786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors.
    Walsh JC; Jones CD; Barnes EA; Gazzard BG; Mitchell SM
    AIDS; 1998 Apr; 12(6):613-8. PubMed ID: 9583601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Course of cytomegalovirus retinitis in HIV positive patients treated with triple antiretroviral therapy].
    Doan S; Badelon I; Chaine G
    J Fr Ophtalmol; 1998 Jan; 21(1):34-41. PubMed ID: 9834898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.
    van den Horn GJ; Meenken C; Danner SA; Reiss P; de Smet MD
    Br J Ophthalmol; 1998 Sep; 82(9):988-90. PubMed ID: 9893585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
    Mitchell SM; Membrey WL; Youle MS; Obi A; Worrell S; Gazzard BG
    Br J Ophthalmol; 1999 Jun; 83(6):652-5. PubMed ID: 10340970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis.
    Sungkanuparph S; Overton ET; Seyfried W; Groger RK; Fraser VJ; Powderly WG
    Clin Infect Dis; 2005 Nov; 41(9):1326-32. PubMed ID: 16206110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the studies on cytomegalovirus retinitis].
    Li HY; Ye JJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):223-7. PubMed ID: 12905727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology and incidence of cytomegalovirus retinitis in the HIV population in Singapore over 6 years.
    Teoh SC; Wang PX; Wong EP
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7546-52. PubMed ID: 23074211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystoid macular edema and cytomegalovirus retinitis in AIDS patients treated with antiretroviral triple therapy].
    Badelon I; Gohier P; Chaine G
    J Fr Ophtalmol; 1999 Dec; 22(10):1034-41. PubMed ID: 10617840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical course of cytomegalovirus retinitis with the different antiretroviral therapies in our hospital].
    Moreno Ruiz O; Ferrer Novella E; Torrón Fernández C; Arazo Garcés P; Melcon Sánchez B; Honrubia López FM
    Arch Soc Esp Oftalmol; 2001 Jul; 76(7):397-402. PubMed ID: 11438875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for cytomegalovirus retinitis in HIV-positive and AIDS patients.
    Sandy CJ; Ferris JD; Bloom PA; Coker RJ; Pinching AJ; Migdal CS
    QJM; 1995 Dec; 88(12):899-903. PubMed ID: 8593550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mycobacterium avium complex disease in HIV seropositive patients: incidence and risk factors before and after the introduction of highly active antiretroviral treatments. Clinical Epidemiology Group of the Information and Care Center for Human Immunodeficiency].
    Mary-Krause M; Rabaud C; Jouan M; Obadia M; de la Blanchardière A; Raffi F; May T
    Pathol Biol (Paris); 2000 Jun; 48(5):495-504. PubMed ID: 10949848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.